AdvertisementThe DOJ Moves To Block The Purdue Pharma Bankruptcy Deal That Shields The SacklersSeptember 16, 2021Brian MannfacebookEmailPurdue Pharma filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The company's headquarters in Stamford, Conn., is shown here in 2019. (Bloomberg/Getty Images)